Fundz

Hbm Alpha Therapeutics Raises Seed Round To Advance Next-Gen Therapies For Endocrine Disorders

PRIVATEJan 26, 2023

Round Type

Seed

CambridgeBiotechnologyHealth CareMedicalTherapeutics

Description

HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced that it completed seed financing to advance its leading programs, novel antibody therapies to treat congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS), with the lead candidate currently in IND-enabling stage.

Quick answer

HBM Alpha Therapeutics raised an undisclosed amount in a Seed round, dated January 26, 2023. HBM Alpha Therapeutics is based in Cambridge, Maryland, United States.

How much did HBM Alpha Therapeutics raise?
HBM Alpha Therapeutics raised an undisclosed amount in a Seed round on January 26, 2023.
What does HBM Alpha Therapeutics do?
HBM Alpha Therapeutics is a company presently developing antibody therapeutics aimed at the rare genetic disease congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS).
Where is HBM Alpha Therapeutics based and how big is it?
HBM Alpha Therapeutics is based in Cambridge, Maryland, United States.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as HBM Alpha Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.
  • Current Surgical raised $3.2M (Seed) on February 21, 2023.
  • Grey Wolf Therapeutics raised $49M (Funding Round) on January 27, 2023.
  • Actimed Therapeutics raised $12M (Seed) on January 4, 2023.
  • Virax Biolabs raised $4M on March 10, 2023.
  • QurAlis raised $88M (Series B) on March 9, 2023.

Who to call at HBM Alpha Therapeutics, and when

A new round usually means HBM Alpha Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day HBM Alpha Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HBM Alpha Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HBM Alpha Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HBM Alpha Therapeutics

Location

Cambridge, Maryland, United States

About

HBM Alpha Therapeutics is a company presently developing antibody therapeutics aimed at the rare genetic disease congenital adrenal hyperplasia (CAH) and polycystic ovary syndrome (PCOS). Its therapeutics could also be indicated for other endocrinological diseases related to the dysregulation and function of the hypothalamus-pituitary-adrenal (HPA) axis. HBMAT was founded and incorporated in Delaware, USA in 2019. It is a joint venture between Harbour BioMed and Boston Children's Hospital, an affiliate of Harvard Medical School. For more information, please visit www.hbmalphatx.com or contact BD@harbourbiomed.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HBM Alpha Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for HBM Alpha Therapeutics's next move

See what Strategic adds

HBM Alpha Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.